We performed the distribution analysis of the mutations in ten typical cancer-related signaling pathways, including TGF-β signaling, Hippo, p53, Nrf2, cell cycle, PI-3-Kinase/Akt, RTK-RAS, Myc, Notch, and β-catenin/Wnt [29]. This evidence concerns the gene TGFB1 and cancer.